Biomolecules and biomarkers used in diagnosis of alcohol drinking and in monitoring therapeutic interventions

Biomolecules

Volumn 5, Issue 3, 2015, Pages 1339-1385

  Nanau, Radu M ^a   Neuman, Manuela G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alcohol; Biomarkers; Breath test; Carbohydrate deficient transferrin; Drinking; Ethyl glucuronide; Ethyl sulfate; Fatty acid ethyl esters; Phosphatidylethanol

Indexed keywords

BIOLOGICAL MARKER; ETHYL GLUCURONIDE; ETHYL SULFATE; FATTY ACID ESTER; GAMMA GLUTAMYLTRANSFERASE; HAND SANITIZER; MOUTHWASH; PHOSPHATIDYLETHANOL; TRANSFERRIN; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; BANANA; BEER; BODY SIZE; BREATH ALCOHOL ANALYZER; BREATH ANALYSIS; CLINICAL TRIAL (TOPIC); DIAGNOSTIC ACCURACY; DRINKING BEHAVIOR; ENERGY DRINK; GLUCURONIDATION; HAIR ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVER TRANSPLANTATION; LUNG CAPACITY; MASS FRAGMENTOGRAPHY; OCCUPATIONAL HAZARD; PATIENT COMPLIANCE; PATIENT MONITORING; PREDICTIVE VALUE; REVIEW; SYSTEMATIC REVIEW; URINALYSIS; ALCOHOLISM; BLOOD; HAIR; METABOLISM; URINE;

HUMAN IMMUNODEFICIENCY VIRUS;

ALCOHOL DRINKING; ALCOHOLISM; BIOMARKERS; BREATH TESTS; HAIR; HUMANS;

EID: 85012066774     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5031339     Document Type: Review

References (247)

1. Neuman, M.G.; Schmilovitz-Weiss, H.; Hilzenrat, N.; Bourliere, M.; Marcellin, P.; Trepo, C.; Mazulli, T.; Moussa, G.; Patel, A.; Baig, A.A. et al. Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int. J. Hepatol. 2012.
2. Neuman, M.G.; Schneider, M.; Nanau, R.M.; Parry, C. Alcohol consumption, progression of the disease and comorbidities and responses to antiretroviral medication in people living with HIV. AIDS Res. Treat. 2012.
3. Patrick, C.H. Alcohol, Culture, and Society; Duke University Press: Durham, NC, USA, 1952.
4. Zimmerman, H.J. The evolution of alcoholic cirrhosis. Med. Clin. N. Am. 1955, 39, 249-251.
5. Shield, K.D.; Rylett, M.; Gmel, G.; Gmel, G.; Kehoe-Chan, T.A.; Rehm, J. Global alcohol exposure estimates by country, territory and region for 2005—A contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction 2013, 108, 912-922.
6. Neuman, M.G.; French, S.W.; French, B.A.; Seitz, H.K.; Cohen, L.B.; Mueller, S.; Osna, N.A.; Kharbanda, K.K.; Seth, D.; Bautista, A. et al. Alcoholic and non-alcoholic steatohepatitis. Exp. Mol. Pathol. 2014, 97, 492-510.
7. Sun, F.; Tsuritani, I.; Yamada, Y. Contribution of genetic polymorphisms in ethanol-metabolizing enzymes to problem drinking behavior in middle-aged Japanese men. Behav. Genet. 2002, 32, 229-236.
8. Wechsler, H.; Austin, S.B. Binge drinking: The five/four measure. J. Stud. Alcohol. 1998, 59, 122-124.
9. Sato, N.; Lindros, K.O.; Baraona, E.; Ikejima, K.; Mezey, E.; Järveläinen, H.A.; Ramchandani, V.A. Sex difference in alcohol-related organ injury. Alcohol. Clin. Exp. Res. 2001, 25, 40S-45S.
10. Pithey, A.; Parry, C. Descriptive systematic review of Sub-Saharan African studies on the association between alcohol use and HIV infection. SAHARA J. 2009, 6, 155-169.
11. Neuman, M.G.; Schneider, M.; Nanau, R.M.; Parry, C. HIV-antiretroviral therapy induced liver, gastrointestinal, and pancreatic injury. Int. J. Hepatol. 2012.
12. Schneider, M.; Chersich, M.; Neuman, M.G.; Parry, C. Alcohol consumption and HIV/AIDS: The neglected interface. Addiction 2012, 107, 1369-1371.
13. Schneider, M.; Neuman, M.G.; Chersich, M.; Parry, C. Alcohol and HIV medication a deadly cocktail. J. AIDS Clin. Res. 2012.
14. Zimmerman, H.J. Hepatotoxicity. In Adverse Effects of Drugs and Other Chemicals on the Liver, 2nd ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 1999.
15. Cohen, C.D.; Sayed, A.R.; Kirsch, R.E. Hepatic complications of antituberculosis therapy revisited. S. Afr. Med. J. 1983, 63, 960-963.
16. Zimmerman, H.J. Hepatotoxicity. In Adverse Effects of Drugs and Other Chemicals on the Liver; Appleton-Century Crofts: New York, NY, USA, 1978.
17. Zimmerman, H.J. Effects of alcohol on other hepatotoxins. Alcohol. Clin. Exp. Res. 1986, 10, 3-15.
18. Mandayam, S.; Jamal, M.M.; Morgan, T.R. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 2004, 24, 217-232.
19. Lim, S.S.; Vos, T.; Flaxman, A.D.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; Amann, M.; Anderson, H.R.; Andrews, K.G.; Aryee, M. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2224-2260.
20. Welte, J.; Barnes, G.; Wieczorek, W.; Tidwell, M.C.; Parker, J. Alcohol and gambling pathology among U.S. adults: Prevalence, demographic patterns and comorbidity. J. Stud. Alcohol. 2001, 62, 706-712.
21. Caetano, R.; Tam, T.; Greenfield, T.; Cherpitel, C.; Midanik, L. DSM-IV alcohol dependence and drinking in the U.S. population: A risk analysis. Ann. Epidemiol. 1997, 7, 542-549.
22. Tam, T.W.; Midanik, L.T. The effect of screening on prevalence estimates of alcohol dependence and social consequences. J. Stud. Alcohol. 2000, 61, 617-621.
23. Rehm, J.; Rehn, N.; Room, R.; Monteiro, M.; Gmel, G.; Jernigan, D.; Frick, U. The global distribution of average volume of alcohol consumption and patterns of drinking. Eur. Addict. Res. 2003, 9, 147-156.
24. Hasin, D.; Paykin, A.; Meydan, J.; Grant, B. Withdrawal and tolerance: Prognostic significance in DSM-IV alcohol dependence. J. Stud. Alcohol. 2000, 61, 431-438.
25. Barrio, E.; Tomé, S.; Rodríguez, I.; Gude, F.; Sánchez-Leira, J.; Pérez-Becerra, E.; González-Quintela, A. Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. Alcohol. Clin. Exp. Res. 2004, 28, 131-136.
26. Rehm, J.; Baliunas, D.; Borges, G.L.; Graham, K.; Irving, H.; Kehoe, T.; Parry, C.D.; Patra, J.; Popova, S.; Poznyak, V. et al. The relation between different dimensions of alcohol consumption and burden of disease: An overview. Addiction 2010, 105, 817-843.
27. Rehm, J. The risks associated with alcohol use and alcoholism. Alcohol. Res. Health 2011, 34, 135-143.
28. Rehm, J.; Frick, U. Establishing disability weights from pairwise comparisons for a US burden of disease study. Int. J. Methods Psychiatr. Res. 2013, 22, 144-154.
29. Rehm, J.; Shield, K.D.; Gmel, G.; Rehm, M.X.; Frick, U. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur. Neuropsychopharmacol. 2013, 23, 89-97.
30. Whiteford, H.A.; Degenhardt, L.; Rehm, J.; Baxter, A.J.; Ferrari, A.J.; Erskine, H.E.; Charlson, F.J.; Norman, R.E.; Flaxman, A.D.; Johns, N. et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet 2013, 382, 1575-1586.
31. Ezzati, M.; Lopez, A.D.; Rodgers, A.; vander Hoorn, S.; Murray, C.J. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360, 1347-1360.
32. Bataille, V.; Ruidavets, J.B.; Arveiler, D.; Amouyel, P.; Ducimetière, P.; Perret, B.; Ferrières, J. Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample. Alcohol 2003, 38, 121-127.
33. Aertgeerts, B.; Buntinx, F.; Kester, A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: A diagnostic meta-analysis. J. Clin. Epidemiol. 2004, 57, 30-39.
34. Saunders, J.B.; Aasland, O.G.; Babor, T.F.; de la Fuente, J.R.; Grant, M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption—II. Addiction 1993, 88, 791-804.
35. Skinner, H.A.; Sheu, W.J. Reliability of alcohol use indices. The lifetime drinking history and the MAST. J. Stud. Alcohol. 1982, 43, 1157-1170.
36. Soderstrom, C.A.; Smith, G.S.; Kufera, J.A.; Dischinger, P.C.; Hebel, J.R.; McDuff, D.R.; Gorelick, D.A.; Ho, S.M.; Kerns, T.J.; Read, K.M. The accuracy of the CAGE, the brief michigan alcoholism screening test, and the alcohol use disorders identification test in screening trauma center patients for alcoholism. J. Trauma 1997, 43, 962-969.
37. MacKenzie, D.; Langa, A.; Brown, T.M. Identifying hazardous or harmful alcohol use in medical admissions: A comparison of audit, cage and brief mast. Alcohol Alcohol. 1996, 31, 591-599.
38. Bradley, K.A.; Bush, K.R.; McDonell, M.B.; Malone, T.; Fihn, S.D. Screening for problem drinking: Comparison of CAGE and AUDIT. J. Gen. Intern. Med. 1998, 13, 379-388.
39. Steinbauer, J.R.; Cantor, S.B.; Holzer, C.E., 3rd; Volk, R.J. Ethnic and sex bias in primary care screening tests for alcohol use disorders. Ann. Intern. Med. 1998, 129, 353-362.
40. Alcañiz, M.; Guillén, M.; Santolino, M.; Sánchez-Moscona, D.; Llatje, O.; Ramon, L. Prevalence of alcohol-impaired drivers based on random breath tests in a roadside survey in Catalonia (Spain). Accid. Anal. Prev. 2014, 65, 131-141.
41. Aguilera, S.L.; Sripad, P.; Lunnen, J.C.; Moyses, S.T.; Chandran, A.; Moysés, S.J. Alcohol consumption among drivers in Curitiba, Brazil. Traffic Inj. Prev. 2015, 16, 219-224.
42. Ontario Ministry of Transportation. Impaired Driving. Available online: http://www.mto.gov.on.ca/english/safety/impaired-driving.shtml (accessed on 6 April 2015).
43. Roiu, I.; Birngruber, C.G.; Spencer, V.C.; Wollersen, H.; Dettmeyer, R.; Verhoff, M.A. A comparison of breath- and blood-alcohol test results from real-life policing situations: A one-year study of data from the Central Hessian Police District in Germany. Forensic Sci. Int. 2013, 232, 125-130.
44. Marques, P.R. Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems. Drug Test. Anal. 2012, 4, 76-82.
45. Starkey, N.J.; Charlton, S.G. The effects of moderate alcohol concentrations on driving and cognitive performance during ascending and descending blood alcohol concentrations. Hum. Psychopharmacol. 2014, 29, 370-383.
46. Lewis, B.; Nixon, S.J. Cognitive flexibility during breath alcohol plateau is associated with previous drinking measures. Alcohol 2013, 47, 333-338.
47. Stübig, T.; Petri, M.; Zeckey, C.; Brand, S.; Müller, C.; Otte, D.; Krettek, C.; Haasper, C. Alcohol intoxication in road traffic accidents leads to higher impact speed difference, higher ISS and MAIS, and higher preclinical mortality. Alcohol 2012, 46, 681-686.
48. Grubb, D.; Rasmussen, B.; Linnet, K.; Olsson, S.G.; Lindberg, L. Breath alcohol analysis incorporating standardization to water vapour is as precise as blood alcohol analysis. Forensic Sci. Int. 2012, 216, 88-91.
49. Jaffe, D.H.; Siman-Tov, M.; Gopher, A. et al. Variability in the blood/breath alcohol ratio and implications for evidentiary purposes. J. Forensic Sci. 2013, 58, 1233-1237.
50. Jaffe, D.H.; Siman-Tov, M.; Gopher, A.; Peleg, K. Variability in the blood/breath alcohol ratio and implications for evidentiary purposes. J. Forensic Sci. 2013, 58, 1233-1237.
51. Ashdown, H.F.; Fleming, S.; Spencer, E.A.; Thompson, M.J.; Stevens, R.J. Diagnostic accuracy study of three alcohol breathalysers marketed for sale to the public. BMJ Open 2014.
52. Lindberg, L.; Brauer, S.; Wollmer, P.; Goldberg, L.; Jones, A.W.; Olsson, S.G. Breath alcohol concentration determined with a new analyzer using free exhalation predicts almost precisely the arterial blood alcohol concentration. Forensic Sci. Int. 2007, 168, 200-207.
53. Andersson, K.A.; Kron, J.; Castren, M.; Athlin, A.; Hok, B.; Wiklund, L. Assessment of the breath alcohol concentration in emergency care patients with different level of consciousness. Scand. J. Trauma Resusc. Emerg. Med. 2015.
54. Kriikku, P.; Wilhelm, L.; Jenckel, S.; Rintatalo, J.; Hurme, J.; Kramer, J.; Jones, A.W.; Ojanperä, I. Comparison of breath-alcohol screening test results with venous blood alcohol concentration in suspected drunken drivers. Forensic Sci. Int. 2014, 239, 57-61.
55. Clapp, J.D.; Min, J.W.; Trim, R.S.; Reed, M.B.; Lange, J.E.; Shillington, A.M.; Croff, J.M. Predictors of error in estimates of blood alcohol concentration: A replication. J. Stud. Alcohol Drugs 2009, 70, 683-688.
56. Lindberg, L.; Grubb, D.; Dencker, D.; Finnhult, M.; Olsson, S.G. Detection of mouth alcohol during breath alcohol analysis. Forensic Sci. Int. 2015, 249, 66-72.
57. Quigg, Z.; Hughes, K.; Bellis, M.A. Student drinking patterns and blood alcohol concentration on commercially organised pub crawls in the UK. Addict. Behav. 2013, 38, 2924-2929.
58. Miller, P.; Pennay, A.; Droste, N.; Butler, E.; Jenkinson, R.; Hyder, S.; Quinn, B.; Chikritzhs, T.; Tomsen, S.; Wadds, P. et al. A comparative study of blood alcohol concentrations in Australian night-time entertainment districts. Drug Alcohol Rev. 2014, 33, 338-345.
59. Verster, J.C.; Benjaminsen, J.M.; van Lanen, J.H.; van Stavel, N.M.; Olivier, B. Effects of mixing alcohol with energy drink on objective and subjective intoxication: Results from a Dutch on-premise study. Psychopharmacology 2015, 232, 835-842.
60. Barry, A.E.; Chaney, B.H.; Stellefson, M.L.; Dodd, V. Validating the ability of a single-item assessing drunkenness to detect hazardous drinking. Am. J. Drug Alcohol Abuse 2013, 39, 320-325.
61. Bertholet, N.; Winter, M.R.; Cheng, D.M.; Samet, J.H.; Saitz, R. How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence? Alcohol Alcohol. 2014, 49, 423-429.
62. Wetterling, T.; Dibbelt, L.; Wetterling, G.; Göder, R.; Wurst, F.; Margraf, M.; Junghanns, K. Ethyl glucuronide (EtG): Better than breathalyser or self-reports to detect covert short-term relapses into drinking. Alcohol Alcohol. 2014, 49, 51-54.
63. Gullberg, R.G.; Polissar, N.L. Factors contributing to the variability observed in duplicate forensic breath alcohol measurement. J. Breath Res. 2011.
64. Andersson, K.A.; Hök, B.; Ekström, M.; Hedenstierna, G. Influence from breathing pattern on alcohol and tracer gas expirograms—Implications for alcolock use. Forensic Sci. Int. 2011, 206, 52-57.
65. Hlastala, M.P.; Anderson, J.C. Breath alcohol analysis incorporating standardization to water vapour is as precise as blood alcohol analysis. Forensic Sci. Int. 2012.
66. Hlastala, M.P. Paradigm shift for the alcohol breath test. J. Forensic Sci. 2010, 55, 451-456.
67. Jones, A.W. Quantitative measurements of the alcohol concentration and the temperature of breath during a prolonged exhalation. Acta Physiol. Scand. 1982, 114, 407-412.
68. Hlastala, M.P.; Anderson, J.C. The impact of breathing pattern and lung size on the alcohol breath test. Ann. Biomed. Eng. 2007, 35, 264-272.
69. Anderson, J.C.; Hlastala, M.P. Breath tests and airway gas exchange. Pulm. Pharmacol. Ther. 2007, 20, 112-117.
70. Sadler, D.W.; Fox, J. Intra-individual and inter-individual variation in breath alcohol pharmacokinetics: The effect of food on absorption. Sci. Justice 2011, 51, 3-9.
71. Xiao, H.T.; He, L.; Tong, R.S.; Yu, J.Y.; Chen, L.; Zou, J.; Li, J.Q.; Bian, Y.; Zhang, Y. Rapid and sensitive headspace gas chromatography-mass spectrometry method for the analysis of ethanol in the whole blood. J. Clin. Lab. Anal. 2014, 28, 386-390.
72. Karakus, A.; İdiz, N.; Dalgiç, M.; Uluçay, T.; Sincar, Y. Comparison of the effects of two legal blood alcohol limits: The presence of alcohol in traffic accidents according to category of driver in Izmir, Turkey. Traffic Inj. Prev. 2015, 16, 440-442.
73. Sutlovic, D.; Scepanovic, A.; Bosnjak, M.; Versic-Bratincevic, M.; Definis-Gojanovic, M. The role of alcohol in road traffic accidents with fatal outcome: 10-Year period in Croatia Split-Dalmatia County. Traffic Inj. Prev. 2014, 15, 222-227.
74. Sutlovic, D.; Versic-Bratincevic, M.; Definis-Gojanovic, M. Blood alcohol stability in postmortem blood samples. Am. J. Forensic Med. Pathol. 2014, 35, 55-58.
75. Bielefeld, L.; Auwärter, V.; Pollak, S.; Thierauf-Emberger, A. Differences between the measured blood ethanol concentration and the estimated concentration by Widmark’s equation in elderly persons. Forensic Sci. Int. 2015, 247, 23-27.
76. Mitchell, M.C., Jr.; Teigen, E.L.; Ramchandani, V.A. Absorption and peak blood alcohol concentration after drinking beer, wine, or spirits. Alcohol. Clin. Exp. Res. 2014, 38, 1200-1204.
77. Maenhout, T.M.; de Buyzere, M.L.; Delanghe, J.R. Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin. Chim. Acta 2013, 415, 322-329.
78. Foti, R.S.; Fisher, M.B. Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci. Int. 2005, 153, 109-116.
79. Schwab, N.; Skopp, G. Identification and preliminary characterization of UDP-glucuronosyltransferases catalyzing formation of ethyl glucuronide. Anal. Bioanal. Chem. 2014, 406, 2325-2332.
80. Zimmer, H.; Schmitt, G.; Aderjan, R. Preliminary immunochemical test for the determination of ethyl glucuronide in serum and urine: Comparison of screening method results with gas chromatography-mass spectrometry. J. Anal. Toxicol. 2002, 26, 11-16.
81. Wurst, F.M.; Skipper, G.E.; Weinmann, W. Ethyl glucuronide—The direct ethanol metabolite on the threshold from science to routine use. Addiction 2003, 98, 51-61.
82. Allen, J.P.; Wurst, F.M.; Thon, N.; Litten, R.Z. Assessing the drinking status of liver transplant patients with alcoholic liver disease. Liver Transpl. 2013, 19, 369-376.
83. Peterson, K. Biomarkers for alcohol use and abuse—A summary. Alcohol Res. Health 2004, 28, 30-37.
84. Kurogi, K.; Davidson, G.; Mohammed, Y.I.; Williams, F.E.; Liu, M.Y.; Sakakibara, Y.; Suiko, M.; Liu, M.C. Ethanol sulfation by the human cytosolic sulfotransferases: A systematic analysis. Biol. Pharm. Bull. 2012, 35, 2180-2185.
85. Marques, P.R.; Tippetts, A.S.; Yegles, M. Ethylglucuronide in hair is a top predictor of impaired driving recidivism, alcohol dependence, and a key marker of the highest BAC interlock tests. Traffic Inj. Prev. 2014, 15, 361-369.
86. Jatlow, P.I.; Agro, A.; Wu, R.; Nadim, H.; Toll, B.A.; Ralevski, E.; Nogueira, C.; Shi, J.; Dziura, J.D.; Petrakis, I.L. et al. Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: Results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol. Clin. Exp. Res. 2014, 38, 2056-2065.
87. Kummer, N.; Wille, S.; di Fazio, V.; Lambert, W.; Samyn, N. A fully validated method for the quantification of ethyl glucuronide and ethyl sulphate in urine by UPLC-ESI-MS/MS applied in a prospective alcohol self-monitoring study. J. Chromatogr. B Analy. Technol. Biomed. Life Sci. 2013, 929, 149-154.
88. Lande, R.G.; Marin, B. A comparison of two alcohol biomarkers in clinical practice: Ethyl glucuronide versus ethyl sulfate. J. Addict. Dis. 2013, 32, 288-292.
89. Lande, R.G.; Marin, B.; Chang, A.S. Clinical application of ethyl glucuronide testing in the U.S. Army. J. Addict. Dis. 2011, 30, 39-44.
90. Staufer, K.; Andresen, H.; Vettorazzi, E.; Tobias, N.; Nashan, B.; Sterneck, M. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology 2011, 54, 1640-1649.
91. Stewart, S.H.; Koch, D.G.; Burgess, D.M.; Willner, I.R.; Reuben, A. Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients. Alcohol. Clin. Exp. Res. 2013, 37, 150-155.
92. Hegstad, S.; Helland, A.; Hagemann, C.; Michelsen, L.; Spigset, O. EtG/EtS in Urine from sexual assault victims determined by UPLC-MS-MS. J. Anal. Toxicol. 2013, 37, 227-232.
93. Winkler, M.; Skopp, G.; Alt, A.; Miltner, E.; Jochum, T.; Daenhardt, C.; Sporkert, F.; Gnann, H.; Weinmann, W.; Thierauf, A. Comparison of direct and indirect alcohol markers with PEth in blood and urine in alcohol dependent inpatients during detoxication. Int. J. Legal Med. 2013, 127, 761-768.
94. Albermann, M.E.; Musshoff, F.; Doberentz, E.; Heesem, P.; Bangerm, M.; Madeam, B. Preliminary investigations on ethyl glucuronide and ethyl sulfate cutoffs for detecting alcohol consumption on the basis of an ingestion experiment and on data from withdrawal treatment. Int. J. Legal Med. 2012, 126, 757-764.
95. Lostia, A.M.; Vicente, J.L.; Cowan, D.A. Measurement of ethyl glucuronide, ethyl sulphate and their ratio in the urine and serum of healthy volunteers after two doses of alcohol. Alcohol Alcohol. 2013, 48, 74-82.
96. Høiseth, G.; Yttredal, B.; Karinen, R.; Gjerde, H.; Mørland, J.; Christophersen, A. Ethyl glucuronide concentrations in oral fluid, blood, and urine after volunteers drank 0.5 and 1.0 g/kg doses of ethanol. J. Anal. Toxicol. 2010, 34, 319-324.
97. Piano, S.; Marchioro, L.; Gola, E.; Rosi, S.; Morando, F.; Cavallin, M.; Sticca, A.; Fasolato, S.; Forza, G.; Frigo, C.A. et al. Assessment of alcohol consumption in liver transplant candidates and recipients: The best combination of the tools available. Liver Transpl. 2014, 20, 815-822.
98. Lahmek, P.; Michel, L.; Diviné, C.; Meunier, N.; Pham, B.; Cassereau, C.; Aussel, C.; Aubin, H.J. Ethyl glucuronide for detecting alcohol lapses in patients with an alcohol use disorder. J. Addict. Med. 2012, 6, 35-38.
99. McDonell, M.G.; Srebnik, D.; Angelo, F.; Sugar, A.M.; Howell, D.; Rainey, C.; Roll, J.; Short, R.; Ries, R. Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients. Am. J. Addict. 2011, 20, 482-484.
100. Dahl, H.; Carlsson, V.A.; Hillgren, K.; Helander, A. Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence. Alcohol Alcohol. 2011, 46, 278-282.
101. Dahl, H.; Hammarberg, A.; Franck, J.; Helander, A. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo. Alcohol Alcohol. 2011, 46, 553-557.
102. Helander, A.; Péter, O.; Zheng, Y. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol. 2012, 47, 552-557.
103. Webzell, I.; Ball, D.; Bell, J.; Sherwood, R.A.; Marsh, A.; O’Grady, J.G.; Heaton, N.D. Substance use by liver transplant candidates: An anonymous urinalysis study. Liver Transpl. 2011, 17, 1200-1204.
104. Marques, P.R.; Tippetts, S.; Allen, J.; Javors, M.; Alling, C.; Yegles, M.; Pragst, F.; Wurst, F. Estimating driver risk using alcohol biomarkers, interlock blood alcoholconcentration tests and psychometric assessments: Initial descriptives. Addiction 2010, 105, 226-239.
105. Rainio, J.; Ahola, S.; Kangastupa, P.; Kultti, J.; Tuomi, H.; Karhunen, P.J.; Helander, A.; Niemelä, O. Comparison of ethyl glucuronide and carbohydrate-deficient transferrin in different body fluids for post-mortem identification of alcohol use. Alcohol Alcohol. 2014, 49, 55-59.
106. Turfus, S.C.; Vo, T.; Niehaus, N.; Gerostamoulos, D.; Beyer, J. An evaluation of the DRI-ETG EIA method for the determination of ethyl glucuronideconcentrations in clinical and post-mortem urine. Drug Test. Anal. 2013, 5, 439-445.
107. Leickly, E.; McDonell, M.G.; Vilardaga, R.; Angelo, F.A.; Lowe, J.M.; McPherson, S.; Srebnik, D.; Roll, J.M.; Ries, R.K. High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry. Am. J. Drug Alcohol Abuse 2015.
108. Helander, A.; Kenan, N.; Beck, O. Comparison of analytical approaches for liquid chromatography/mass spectrometry determination of the alcohol biomarker ethyl glucuronide in urine. Rapid Commun. Mass Spectrom. 2010, 24, 1737-1743.
109. Høiseth, G.; Nordal, K.; Pettersen, E.; Mørland, J. Prolonged urinary detection times of EtG and EtS in patients with decreased renal function. Alcohol. Clin. Exp. Res. 2012, 36, 1148-1151.
110. Høiseth, G.; Yttredal, B.; Karinen, R.; Gjerde, H.; Christophersen, A. Levels of ethyl glucuronide and ethyl sulfate in oral fluid, blood, and urine after use of mouthwash and ingestion of nonalcoholic wine. J. Anal. Toxicol. 2010, 34, 84-88.
111. Reisfield, G.M.; Goldberger, B.A.; Pesce, A.J.; Crews, B.O.; Wilson, G.R.; Teitelbaum, S.A.; Bertholf, R.L. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash. J. Anal. Toxicol. 2011, 35, 264-268.
112. Reisfield, G.M.; Goldberger, B.A.; Crews, B.O.; Pesce, A.J.; Wilson, G.R.; Teitelbaum, S.A.; Bertholf, R.L. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to an ethanol-based hand sanitizer. J. Anal. Toxicol. 2011, 35, 85-91.
113. Arndt, T.; Schröfel, S.; Güssregen, B.; Stemmerich, K. Inhalation but not transdermal resorption of hand sanitizer ethanol causes positive ethyl glucuronide findings in urine. Forensic Sci. Int. 2014, 237, 126-130.
114. Musshoff, F.; Albermann, E.; Madea, B. Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods—Misleading results? Int. J. Legal Med. 2010, 124, 623-630.
115. Thierauf, A.; Wohlfarth, A.; Auwärter, V.; Perdekamp, M.G.; Wurst, F.M.; Weinmann, W. Urine tested positive for ethyl glucuronide and ethyl sulfate after the consumption of yeast and sugar. Forensic Sci. Int. 2010, 202, e45-e47.
116. Thierauf, A.; Gnann, H.; Wohlfarth, A.; Auwärter, V.; Perdekamp, M.G.; Buttler, K.J.; Wurst, F.M.; Weinmann, W. Urine tested positive for ethyl glucuronide and ethyl sulphate after the consumption of “non-alcoholic” beer. Forensic Sci. Int. 2010, 202, 82-85.
117. Al Saabi, A.; Allorge, D.; Sauvage, F.L.; Tournel, G.; Gaulier, J.M.; Marquet, P.; Picard, N. Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse. Drug Metab. Dispos. 2013, 41, 568-574.
118. Skipper, G.E.; Thon, N.; Dupont, R.L.; Baxter, L.; Wurst, F.M. Phosphatidylethanol: The potential role in further evaluating low positive urinaryethyl glucuronide and ethyl sulfate results. Alcohol. Clin. Exp. Res. 2013, 37, 1582-1586.
119. Gnann, H.; Engelmann, C.; Skopp, G.; Winkler, M.; Auwärter, V.; Dresen, S.; Ferreirós, N.; Wurst, F.M.; Weinmann, W. Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS/MS. Anal. Bioanal. Chem. 2010, 396, 2415-2423.
120. Nalesso, A.; Viel, G.; Cecchetto, G.; Mioni, D.; Pessa, G.; Favretto, D.; Ferrara, S.D. Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry. J. Chromatogr. A 2011, 1218, 8423-8431.
121. Varga, A.; Hansson, P.; Johnson, G.; Alling, C. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin. Chim. Acta 2000, 299, 141-150.
122. Stewart, S.H.; Law, T.L.; Randall, P.K.; Newman, R. Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol. Clin. Exp. Res. 2010, 34, 488-492.
123. Kwak, H.S.; Han, J.Y.; Ahn, H.K.; Kim, M.H.; Ryu, H.M.; Kim, M.Y.; Chung, H.J.; Cho, D.H.; Shin, C.Y.; Velazquez-Armenta, E.Y. et al. Blood levels of phosphatidylethanol in pregnant women reporting positive alcohol ingestion, measured by an improved LC-MS/MS analytical method. Clin. Toxicol. 2012, 50, 886-891.
124. Kwak, H.S.; Han, J.Y.; Choi, J.S.; Ahn, H.K.; Ryu, H.M.; Chung, H.J.; Cho, D.H.; Shin, C.Y.; Velazquez-Armenta, E.Y.; Nava-Ocampo, A.A. Characterization of phosphatidylethanol blood concentrations for screening alcohol consumption in early pregnancy. Clin. Toxicol. 2014, 52, 25-31.
125. Hahn, J.A.; Dobkin, L.M.; Mayanja, B.; Emenyonu, N.I.; Kigozi, I.M.; Shiboski, S.; Bangsberg, D.R.; Gnann, H.; Weinmann, W.; Wurst, F.M. Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol. Clin. Exp. Res. 2012, 36, 854-862.
126. Bajunirwe, F.; Haberer, J.E.; Boum, Y., 2nd; Hunt, P.; Mocello, R.; Martin, J.N.; Bangsberg, D.R.; Hahn, J.A. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS ONE 2014, 9, e113152.
127. Stewart, S.H.; Koch, D.G.; Willner, I.R.; Anton, R.F.; Reuben, A. Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol. Clin. Exp. Res. 2014, 38, 1706-1711.
128. Gnann, H.; Weinmann, W.; Thierauf, A. Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Alcohol. Clin. Exp. Res. 2012, 36, 1507-1511.
129. Gnann, H.; Weinmann, W.; Engelmann, C.; Wurst, F.M.; Skopp, G.; Winkler, M.; Thierauf, A.; Auwärter, V.; Dresen, S.; Bouzas, F.N. Selective detection of phosphatidylethanol homologues in blood as biomarkers for alcohol consumption by LC-ESI-MS/MS. J. Mass Spectrom. 2009, 44, 1293-1299.
130. Cabarcos, P.; Hassan, H.M.; Tabernero, M.J.; Scott, K.S. Analysis of ethyl glucuronide in hair samples by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS). J. Appl. Toxicol. 2013, 33, 638-643.
131. Isaksson, A.; Walther, L.; Hansson, T.; Andersson, A.; Alling, C. Phosphatidylethanol in blood (B-PEth): A marker for alcohol use and abuse. Drug Test. Anal. 2011, 3, 195-200.
132. Hansson, P.; Caron, M.; Johnson, G.; Gustavsson, L.; Alling, C. Blood phosphatidylethanol as a marker of alcohol abuse: Levels in alcoholic males during withdrawal. Alcohol. Clin. Exp. Res. 1997, 21, 108-110.
133. Aradottir, S.; Asanovska, G.; Gjerss, S.; Hansson, P.; Alling, C. PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol. 2006, 41, 431-437.
134. Jain, J.; Evans, J.L.; Briceño, A.; Page, K.; Hahn, J.A. Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users. Alcohol Alcohol. 2014, 49, 520-524.
135. Viel, G.; Boscolo-Berto, R.; Cecchetto, G.; Fais, P.; Nalesso, A.; Ferrara, S.D. Phosphatidylethanol in blood as a marker of chronic alcohol use: A systematic review and meta-analysis. Int. J. Mol. Sci. 2012, 13, 14788-14812.
136. Helander, A.; Zheng, Y. Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 2009, 55, 1395-1405.
137. Marques, P.R.; Hansson, T.; Isaksson, A.; Walther, L.; Jones, J.; Lewis, D.; Jones, M. Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Inj. Prev. 2011, 12, 136-141.
138. Wurst, F.M.; Thon, N.; Aradottir, S.; Hartmann, S.; Wiesbeck, G.A.; Lesch, O.; Skala, K.; Wolfersdorf, M.; Weinmann, W.; Alling, C. Phosphatidylethanol: Normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict. Biol. 2010, 15, 88-95.
139. Stewart, S.H.; Reuben, A.; Brzezinski, W.A.; Koch, D.G.; Basile, J.; Randall, P.K.; Miller, P.M. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol. 2009, 44, 464-467.
140. Comasco, E.; Hallberg, G.; Helander, A.; Oreland, L.; Sundelin-Wahlsten, V. Alcohol consumption among pregnant women in a Swedish sample and its effects on the newborn outcomes. Alcohol. Clin. Exp. Res. 2012, 36, 1779-1786.
141. Crunelle, C.L.; Yegles, M.; van Nuijs, A.L.; Covaci, A.; de Doncker, M.; Maudens, K.E.; Sabbe, B.; Dom, G.; Lambert, W.E.; Michielsen, P. et al. Hair ethyl glucuronide levels as a marker for alcohol use and abuse: A review of the current state of the art. Drug Alcohol. Depend. 2014, 134, 1-11.
142. Crunelle, C.L.; Cappelle, D.; Covaci, A.; van Nuijs, AL.; Maudens, K.E.; Sabbe, B.; Dom, G.; Michielsen, P.; Yegles, M.; Neels, H. Hair ethyl glucuronide as a biomarker of alcohol consumption in alcohol-dependent patients: Role of gender differences. Drug Alcohol. Depend. 2014, 141, 163-166.
143. Kintz, P. Consensus of the society of hair testing on hair testing for chronic excessivealcohol consumption 2009. Forensic Sci. Int. 2010.
144. Kintz, P. Consensus of the society of hair testing on hair testing for chronic excessivealcohol consumption 2011. Forensic Sci. Int. 2012.
145. Pirro, V.; di Corcia, D.; Pellegrino, S.; Vincenti, M.; Sciutteri, B.; Salomone, A. A study of distribution of ethyl glucuronide in different keratin matrices. Forensic Sci. Int. 2011, 210, 271-277.
146. Lees, R.; Kingston, R.; Williams, T.M.; Henderson, G.; Lingford-Hughes, A.; Hickman, M. Comparison of ethyl glucuronide in hair with self-reported alcohol consumption. Alcohol Alcohol. 2012, 47, 267-272.
147. Kharbouche, H.; Faouzi, M.; Sanchez, N.; Daeppen, J.B.; Augsburger, M.; Mangin, P.; Staub, C.; Sporkert, F. Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: A comparison with traditional biomarkers. Int. J. Legal Med. 2012, 126, 243-250.
148. Yaldiz, F.; Daglioglu, N.; Hilal, A.; Keten, A.; Gülmen, M.K. Determination of ethyl glucuronide in human hair by hydrophilic interaction liquid chromatography-tandem mass spectrometry. J. Forensic Leg. Med. 2013, 20, 799-802.
149. Sterneck, M.; Yegles, M.; von Rothkirch, G.; Staufer, K.; Vettorazzi, E.; Schulz, K.H.; Tobias, N.; Graeser, C.; Fischer, L.; Nashan, B. et al. Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates. Liver Int. 2014, 34, 469-476.
150. Stewart, S.H.; Koch, D.G.; Willner, I.R.; Randall, P.K.; Reuben, A. Hair ethyl glucuronide is highly sensitive and specific for detecting moderate-to-heavy drinking in patients with liver disease. Alcohol Alcohol. 2013, 48, 83-87.
151. Hilke, A.; von Rothkirch, G.; Eik, V.; Alexander, M.; Ansgar, L.; Dorothea, F.; Barbara, S.; Bjoern, N.; Martina, S. Determination of ethyl glucuronide in hair for detection of alcohol consumption in patients after liver transplantation. Ther. Drug Monit. 2014.
152. Hastedt, M.; Herre, S.; Pragst, F.; Rothe, M.; Hartwig, S. Workplace alcohol testing program by combined use of ethyl glucuronide and fatty acid ethyl esters in hair. Alcohol Alcohol. 2012, 47, 127-132.
153. Muskovich, M.; Haag-Dawoud, M. Alcohol consumption among drivers subject to the Swiss license restriction of zero tolerance when driving. Traffic Inj. Prev. 2012, 13, 537-543.
154. Pianta, A.; Liniger, B.; Baumgartner, M.R. Ethyl glucuronide in scalp and non-head hair: An intra-individual comparison. Alcohol Alcohol. 2013, 48, 295-302.
155. Albermann, M.E.; Musshoff, F.; Madea, B. Comparison of ethyl glucuronide (EtG) and fatty acid ethyl esters (FAEEs) concentrations in hair for testing abstinence. Anal. Bioanal. Chem. 2011, 400, 175-181.
156. Morini, L.; Varango, C.; Filippi, C.; Rusca, C.; Danesino, P.; Cheli, F.; Fusini, M.; Iannello, G.; Groppi, A. Chronic excessive alcohol consumption diagnosis: Comparison between traditional biomarkers and ethyl glucuronide in hair, a study on a real population. Ther. Drug Monit. 2011, 33, 654-657.
157. Hastedt, M.; Büchner, M.; Rothe, M.; Gapert, R.; Herre, S.; Krumbiegel, F.; Tsokos, M.; Kienast, T.; Heinz, A.; Hartwig, S. Detecting alcohol abuse: Traditional blood alcohol markers compared to ethyl glucuronide (EtG) and fatty acid ethyl esters (FAEEs) measurement in hair. Forensic Sci. Med. Pathol. 2013, 9, 471-477.
158. Pirro, V.; Valente, V.; Oliveri, P.; de Bernardis, A.; Salomone, A.; Vincenti, M. Chemometric evaluation of nine alcohol biomarkers in a large population of clinically-classified subjects: Pre-eminence of ethyl glucuronide concentration in hair for confirmatory classification. Anal. Bioanal. Chem. 2011, 401, 2153-2164.
159. Imbert, L.; Gaulier, J.M.; Dulaurent, S.; Morichon, J.; Bevalot, F.; Izac, P.; Lachâtre, G. Improved liquid chromatography-tandem mass spectrometric method for the determination of ethyl glucuronide concentrations in hair: Applications to forensic cases. Int. J. Leg. Med. 2014, 128, 53-58.
160. Boscolo-Berto, R.; Viel, G.; Montisci, M.; Terranova, C.; Favretto, D.; Ferrara, S.D. Ethyl glucuronide concentration in hair for detecting heavy drinking and/or abstinence: A meta-analysis. Int. J. Leg. Med. 2013, 127, 611-619.
161. Kronstrand, R.; Brinkhagen, L.; Nyström, F.H. Ethyl glucuronide in human hair after daily consumption of 16 or 32 g of ethanol for 3 months. Forensic Sci. Int. 2012, 215, 51-55.
162. Bertol, E.; del Bravo, E.; Vaiano, F.; Mari, F.; Favretto, D. Fatty acid ethyl esters in hair: Correlation with self-reported ethanol intake in 160 subjects and influence of estroprogestin therapy. Drug Test. Anal. 2014, 6, 930-935.
163. Süsse, S.; Selavka, C.M.; Mieczkowski, T.; Pragst, F. Fatty acid ethyl ester concentrations in hair and self-reported alcohol consumption in 644 cases from different origin. Forensic Sci. Int. 2010, 196, 111-117.
164. Süsse, S.; Pragst, F.; Mieczkowski, T.; Selavka, C.M.; Elian, A.; Sachs, H.; Hastedt, M.; Rothe, M.; Campbell, J. Practical experiences in application of hair fatty acid ethyl esters and ethyl glucuronide for detection of chronic alcohol abuse in forensic cases. Forensic Sci. Int. 2012, 218, 82-91.
165. Agius, R.; Nadulski, T.; Kahl, H.G.; Dufaux, B. Ethyl glucuronide in hair—A highly effective test for the monitoring of alcohol consumption. Forensic Sci. Int. 2012, 218, 10-14.
166. Liniger, B.; Nguyen, A.; Friedrich-Koch, A.; Yegles, M. Abstinence monitoring of suspected drinking drivers: Ethyl glucuronide in hair versus CDT. Traffic Inj. Prev. 2010, 11, 123-126.
167. Albermann, M.E.; Madea, B.; Musshoff, F. A SPME-GC/MS procedure for the determination of fatty acid ethyl esters in hair for confirmation of abstinence test results. J. Chromatogr. Sci. 2014, 52, 955-960.
168. Pragst, F.; Rothe, M.; Moench, B.; Hastedt, M.; Herre, S.; Simmert, D. Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: Interpretation and advantages. Forensic Sci. Int. 2010, 196, 101-110.
169. Lendoiro, E.; González-Colmenero, E.; Concheiro-Guisán, A.; de Castro, A.; Cruz, A.; López-Rivadulla, M.; Concheiro, M. Maternal hair analysis for the detection of illicit drugs, medicines, and alcoholexposure during pregnancy. Ther. Drug Monit. 2013, 35, 296-304.
170. Pirro, V.; di Corcia, D.; Seganti, F.; Salomone, A.; Vincenti, M. Determination of ethyl glucuronide levels in hair for the assessment of alcohol abstinence. Forensic Sci. Int. 2013, 232, 229-236.
171. Pragst, F. Interpretation problems in a forensic case of abstinence determination using alcohol markers in hair. Forensic Sci. Int. 2012, 217, e4-e7.
172. Arndt, T.; Schröfel, S.; Stemmerich, K. Ethyl glucuronide identified in commercial hair tonics. Forensic Sci. Int. 2013, 231, 195-198.
173. Kerekes, I.; Yegles, M. Coloring, bleaching, and perming: Influence on EtG content in hair. Ther. Drug Monit. 2013, 35, 527-529.
174. Crunelle, C.L.; Yegles, M.; de Doncker, M.; Dom, G.; Cappelle, D.; Maudens, K.E.; van Nuijs, A.L.; Covaci, A.; Neels, H. Influence of repeated permanent coloring and bleaching on ethyl glucuronide concentrations in hair from alcohol-dependent patients. Forensic Sci. Int. 2015, 247, 18-22.
175. Ettlinger, J.; Kirchen, L.; Yegles, M. Influence of thermal hair straightening on ethyl glucuronide content in hair. Drug Test. Anal. 2014, 6, 74-77.
176. Binz, T.M.; Baumgartner, M.R.; Kraemer, T. The influence of cleansing shampoos on ethyl glucuronide concentration in hair analyzed with an optimized and validated LC-MS/MS method. Forensic Sci. Int. 2014, 244, 20-24.
177. Høiseth, G.; Morini, L.; Ganss, R.; Nordal, K.; Mørland, J. Higher levels of hair ethyl glucuronide in patients with decreased kidney function. Alcohol. Clin. Exp. Res. 2013, 37, E14-E16.
178. Agius, R.; Ferreira, L.M.; Yegles, M. Can ethyl glucuronide in hair be determined only in 3 cm hair strands? Forensic Sci. Int. 2012, 218, 3-9.
179. Süsse, S.; Blueml, M.; Pragst, F. Effect of the analyzed hair length on fatty acid ethyl ester (FAEE) concentrations in hair—Is there congruence of cut-offs for 0-3 and 0-6 cm hair segments? Forensic Sci. Int. 2015, 249, 1-5.
180. Mönch, B.; Becker, R.; Nehls, I. Quantification of ethyl glucuronide in hair: Effect of milling on extraction efficiency. Alcohol Alcohol. 2013, 48, 558-563.
181. Kummer, N.; Wille, S.M.; di Fazio, V.; del mar Ramírez Fernández, M.; Yegles, M.; Lambert, W.E.; Samyn, N. Impact of the grinding process on the quantification of ethyl glucuronide in hair using a validated UPLC-ESI-MS-MS method. J. Anal. Toxicol. 2015, 39, 17-23.
182. Bossers, L.C.; Paul, R.; Berry, A.J.; Kingston, R.; Middendorp, C.; Guwy, A.J. An evaluation of washing and extraction techniques in the analysis of ethyl glucuronide and fatty acid ethyl esters from hair samples. J. Chromatogr. B Analy. Technol. Biomed. Life Sci. 2014, 953-954, 115-119.
183. Salomone, A.; Pirro, V.; Lombardo, T.; di Corcia, D.; Pellegrino, S.; Vincenti, M. Interpretation of group-level factors from a large population dataset in the determination of ethyl glucuronide in hair. Drug Test. Anal. 2014.
184. Gareri, J.; Rao, C.; Koren, G. Examination of sex differences in fatty acid ethyl ester and ethyl glucuronide hair analysis. Drug Test. Anal. 2014, 6, 30-36.
185. Kintz, P.; Nicholson, D. Testing for ethanol markers in hair: Discrepancies after simultaneous quantification of ethyl glucuronide and fatty acid ethyl esters. Forensic Sci. Int. 2014, 243, 44-46.
186. Kerekes, I.; Yegles, M.; Grimm, U.; Wennig, R. Ethyl glucuronide determination: Head hair versus non-head hair. Alcohol Alcohol. 2009, 44, 62-66.
187. Schräder, J.; Rothe, M.; Pragst, F. Ethyl glucuronide concentrations in beard hair after a single alcohol dose: Evidence for incorporation in hair root. Int. J. Leg. Med. 2012, 126, 791-799.
188. Jones, A.W. Biomarkers of recent drinking, retrograde extrapolation of blood-alcohol concentration and plasma-to-blood distribution ratio in a case of driving under the influence of alcohol. J. Forensic Leg. Med. 2011, 18, 213-216.
189. Redondo, H.A.; Schroeck, A.; Kneubuehl, B.; Weinmann, W. Determination of ethyl glucuronide and ethyl sulfate from dried blood spots. Int. J. Leg. Med. 2013, 127, 769-775.
190. Bogstrand, S.T.; Høiseth, G.; Rossow, I.; Normann, P.T.; Ekeberg, O. Prevalence of ethyl glucuronide and ethyl sulphate among patients injured when driving or at work. Alcohol Alcohol. 2015, 50, 68-73.
191. Morini, L.; Colucci, M.; Ruberto, M.G.; Groppi, A. Determination of ethyl glucuronide in nails by liquid chromatography tandem mass spectrometry as a potential new biomarker for chronic alcohol abuse and binge drinking behavior. Anal. Bioanal. Chem. 2012, 402, 1865-1870.
192. Berger, L.; Fendrich, M.; Jones, J.; Fuhrmann, D.; Plate, C.; Lewis, D. Ethyl glucuronide in hair and fingernails as a long-term alcohol biomarker. Addiction 2014, 109, 425-431.
193. Høiseth, G.; Karinen, R.; Christophersen, A.; Mørland, J. Practical use of ethyl glucuronide and ethyl sulfate in postmortem cases as markers of antemortem alcohol ingestion. Int. J. Leg. Med. 2010, 124, 143-148.
194. Krabseth, H.; Mørland, J.; Høiseth, G. Assistance of ethyl glucuronide and ethyl sulfate in the interpretation of postmortem ethanol findings. Int. J. Leg. Med. 2014, 128, 765-770.
195. Sundström, M.; Jones, A.W.; Ojanperä, I. Utility of urinary ethyl glucuronide analysis in post-mortem toxicology when investigating alcohol-related deaths. Forensic Sci. Int. 2014, 241, 178-182.
196. Zeren, C.; Keten, A.; Çelik, S.; Damlar, I.; Daglıoglu, N.; Çeliker, A.; Karaarslan, B. Demonstration of ethyl glucuronide in dental tissue samples by liquid chromatography/electro-spray tandem mass spectrometry. J. Forensic Leg. Med. 2013, 20, 706-710.
197. Daves, M.; Cemin, R.; Floreani, M.; Pusceddu, I.; Cosio, G.; Lippi, G. Comparative evaluation of capillary zone electrophoresis and HPLC in the determination of carbohydrate-deficient transferrin. Clin. Chem. Lab. Med. 2011, 49, 1677-1680.
198. Chrostek, L.; Cylwik, B.; Szmitkowski, M.; Korcz, W. The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence. Clin. Chim. Acta 2006, 364, 167-171.
199. Chrostek, L.; Cylwik, B.; Gruszewska, E.; Tobolczyk, J. The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values? Alcohol 2012, 46, 69-73.
200. Jeppsson, J.O.; Arndt, T.; Schellenberg, F.; Wielders, J.P.; Anton, R.F.; Whitfield, J.B.; Helander, A. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin. Chem. Lab. Med. 2007, 45, 558-562.
201. Helander, A.; Modén, K.N. Effect of transferrin glycation on the use of carbohydrate-deficient transferrin as analcohol biomarker. Alcohol Alcohol. 2013, 48, 478-482.
202. Lesch, O.M.; Walter, H.; Freitag, H.; Heggli, D.E.; Leitner, A.; Mader, R.; Neumeister, A.; Passweg, V.; Pusch, H.; Semler, B. et al. Carbohydrate-deficient transferrin as a screening marker for drinking in a general hospital population. Alcohol Alcohol. 1996, 31, 249-256.
203. Lesch, O.M.; Walter, H.; Antal, J.; Heggli, D.E.; Kovacz, A.; Leitner, A.; Neumeister, A.; Stumpf, I.; Sundrehagen, E.; Kasper, S. Carbohydrate-deficient transferrin as a marker of alcohol intake: A study with healthy subjects. Alcohol Alcohol. 1996, 31, 265-271.
204. Kim, S.G.; Kim, J.S.; Kim, S.S.; Jung, J.G.; Yun, S.J.; Kim, E.C. Relationships between the level of alcohol consumption and abnormality in biomarkers according to facial flushing in Korean male drinkers. Korean J. Fam. Med. 2013, 34, 123-130.
205. Maenhout, T.M.; Baten, G.; de Buyzere, M.L.; Delanghe, J.R. Carbohydrate deficient transferrin in a driver’s license regranting program. Alcohol Alcohol. 2012, 47, 253-260.
206. Shipton, D.; Tappin, D.; Sherwood, R.; Mactier, H.; Aitken, D.; Crossley, J. Monitoring population levels of alcohol consumption in pregnant women: A case for using biomarkers. Subst Use Misuse 2013, 48, 569-573.
207. Gonzalo, P.; Pecquet, M.; Bon, C.; Gonzalo, S.; Radenne, S.; Augustin-Normand, C.; Souquet, J.C. Clinical performance of the carbohydrate-deficient transferrin (CDT) assay by the Sebia Capillarys2 system in case of cirrhosis. Interest of the Bio-Rad %CDT by HPLC test and Siemens N-Latex CDT kit as putative confirmatory methods. Clin. Chim. Acta 2012, 413, 712-718.
208. Thiesen, H.; Hesse, M. Biological markers of problem drinking in homeless patients. Addict. Behav. 2010, 35, 260-262.
209. Hahn, J.A.; Bwana, M.B.; Javors, M.A.; Martin, J.N.; Emenyonu, N.I.; Bangsberg, D.R. Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda. AIDS Behav. 2010, 14, 1265-1268.
210. Ireland, J.; Cheng, D.M.; Samet, J.H.; Bridden, C.; Quinn, E.; Saitz, R. Operating characteristics of carbohydrate-deficient transferrin (CDT) for identifying unhealthy alcohol use in adults with HIV infection. AIDS Care 2011, 23, 1483-1491.
211. Madhubala, V.; Subhashree, A.R.; Shanthi, B. Serum carbohydrate deficient transferrin as a sensitive marker in diagnosingalcohol abuse: A case—Control study. J. Clin. Diagn. Res. 2013, 7, 197-200.
212. Ridinger, M.; Köhl, P.; Gäbele, E.; Wodarz, N.; Schmitz, G.; Kiefer, P.; Hellerbrand, C. Analysis of carbohydrate deficient transferrin serum levels during abstinence. Exp. Mol. Pathol. 2012, 92, 50-53.
213. Chrostek, L.; Cylwik, B.; Gruszewska, E.; Panasiuk, A.; Szmitkowski, M. N-Latex CDT results in liver diseases. Alcohol Alcohol. 2012, 47, 428-432.
214. Popović, V.; Atanasijević, T.; Nikolić, S.; Bozić, N.; Vujcić, Z.; Micić-Labudović, J. Forensic aspects of postmortem serum carbohydrate-deficient transferrin analysis as a marker of alcohol abuse. Srp. Arh. Celok. Lek. 2013, 141, 203-206.
215. Whitfield, J.B.; Heath, A.C.; Madden, P.A.; Pergadia, M.L.; Montgomery, G.W.; Martin, N.G. Metabolic and biochemical effects of low-to-moderate alcohol consumption. Alcohol. Clin. Exp. Res. 2013, 37, 575-586.
216. McDonald, H.; Borinskya, S.; Kiryanov, N.; Gil, A.; Helander, A.; Leon, D.A. Comparative performance of biomarkers of alcohol consumption in a population sample of working-aged men in Russia: The Izhevsk Family Study. Addiction 2013, 108, 1579-1589.
217. McAleer, M.A.; Mason, D.L.; Cunningham, S.; O’Shea, S.J.; McCormick, P.A.; Stone, C.; Collins, P.; Rogers, S.; Kirby, B. Alcohol misuse in patients with psoriasis: Identification and relationship to disease severity and psychological distress. Br. J. Dermatol. 2011, 164, 1256-1261.
218. Lott, J.A.; Curtis, L.W.; Thompson, A.; Gechlik, G.A.; Rund, D.A. Reported alcohol consumption and the serum carbohydrate-deficient transferrin test in third-year medical students. Clin. Chim. Acta 1998, 276, 129-141.
219. Bianchi, V.; Ivaldi, A.; Raspagni, A.; Arfini, C.; Vidali, M. Use of carbohydrate-deficient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffic medicine. Alcohol Alcohol. 2010, 45, 247-251.
220. Bianchi, V.; Premaschi, S.; Raspagni, A.; Secco, S.; Vidali, M. A comparison between serum carbohydrate-deficient transferrin and hair ethyl glucuronide in detecting chronic alcohol consumption in routine. Alcohol Alcohol. 2015.
221. Couture, S.; Brown, T.G.; Tremblay, J.; ng Ying Kin, N.M.; Ouimet, M.C.; Nadeau, L. Are biomarkers of chronic alcohol misuse useful in the assessment of DWI recidivism status? Accid. Anal. Prev. 2010, 42, 307-312.
222. Berlakovich, G.A.; Windhager, T.; Freundorfer, E.; Lesch, O.M.; Steininger, R.; Mühlbacher, F. Carbohydrate deficient transferrin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation 1999, 67, 1231-1235.
223. Fagan, K.J.; Irvine, K.M.; McWhinney, B.C.; Fletcher, L.M.; Horsfall, L.U.; Johnson, L.; O’Rourke, P.; Martin, J.; Scott, I.; Pretorius, C.J. et al. Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers. BMC Gastroenterol. 2014.
224. Chatzipanagiotou, S.; Kalykaki, M.; Tzavellas, E.; Karaiskos, D.; Paparrigopoulos, T.; Liappas, A.; Nicolaou, C.; Michalopoulou, M.; Zoga, M.; Boufidou, F. et al. Alteration of biological markers in alcohol-dependent individuals without liver disease during the detoxification therapy. In Vivo 2010, 24, 325-328.
225. Whitfield, J.B.; Dy, V.; Madden, P.A.; Heath, A.C.; Martin, N.G.; Montgomery, G.W. Measuring carbohydrate-deficient transferrin by direct immunoassay: Factors affecting diagnostic sensitivity for excessive alcohol intake. Clin. Chem. 2008, 54, 1158-1165.
226. Fagan, K.J.; Irvine, K.M.; McWhinney, B.C.; Fletcher, L.M.; Horsfall, L.U.; Johnson, L.A.; Clouston, A.D.; Jonsson, J.R.; O’Rourke, P.; Martin, J. et al. BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin. Alcohol. Clin. Exp. Res. 2013, 37, 1771-1778.
227. Bianchi, V.; Ivaldi, A.; Raspagni, A.; Arfini, C.; Vidali, M. Pregnancy and variations of carbohydrate-deficient transferrin levels measured by the candidate reference HPLC method. Alcohol Alcohol. 2011, 46, 123-127.
228. Kenan, N.; Larsson, A.; Axelsson, O.; Helander, A. Changes in transferrin glycosylation during pregnancy may lead to false-positivecarbohydrate-deficient transferrin (CDT) results in testing for riskful alcohol consumption. Clin. Chim. Acta 2011, 412, 129-133.
229. Stauber, R.E.; Vollmann, H.; Pesserl, I.; Jauk, B.; Lipp, R.; Halwachs, G.; Wilders-Truschnig, M. Carbohydrate-deficient transferrin in healthy women: Relation to estrogens and iron status. Alcohol. Clin. Exp. Res. 1996, 20, 1114-1117.
230. Sillanaukee, P.; Alho, H.; Strid, N.; Jousilahti, P.; Vartiainen, E.; Olsson, U.; Sillanaukee, P. Effect of hormone balance on carbohydrate-deficient transferrin and gamma-glutamyltransferase in female social drinkers. Alcohol. Clin. Exp. Res. 2000, 24, 1505-1509.
231. La Grange, L.; Anton, R.F.; Garcia, S.; Herrbold, C. Carbohydrate-deficient transferrin levels in a female population. Alcohol. Clin. Exp. Res. 1995, 19, 100-103.
232. Anton, R.F.; Lieber, C.; Tabakoff, B. Carbohydrate-deficient transferrin and γ-glutamyltransferase for the detection and monitoring of alcohol use: Results from a multisite study. Alcohol. Clin. Exp. Res. 2002, 26, 1215-1222.
233. De Feo, T.M.; Fargion, S.; Duca, L.; Mattioli, M.; Cappellini, M.D.; Sampietro, M.; Cesana, B.M.; Fiorelli, G. Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology 1999, 29, 658-663.
234. Bell, H.; Tallaksen, C.; Sjåheim, T.; Weberg, R.; Raknerud, N.; Orjasaeter, H.; Try, K.; Haug, E. Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcohol. Clin. Exp. Res. 1993, 17, 246-252.
235. Meregalli, M.; Giacomini, V.; Lino, S.; Marchetti, L.; DeFeo, T.; Cappellini, M.D.; Fiorelli, G. Carbohydrate-deficient transferrin in alcohol and nonalcohol abusers with liver disease. Alcohol. Clin. Exp. Res. 1995, 19, 1525-1527.
236. Bean, P.; Sutphin, M.S.; Liu, Y.; Anton, R.; Reynolds, T.B.; Shoenfeld, Y.; Peter, J.B. Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: Differential diagnosis by detection of mitochondrial autoantibodies. Clin. Chem. 1995, 41, 858-861.
237. Schmitt, U.M.; Stieber, P.; Jüngst, D.; Bilzer, M.; Wächtler, M.; Heberger, S.; Seidel, D. Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur. J. Clin. Investig. 1998, 28, 615-621.
238. Moon, H.W.; Yun, Y.M.; Kim, S.; Choe, W.H.; Hur, M.; Kim, J.Q. Determination of carbohydrate-deficient transferrin levels by using capillary electrophoresis in a Korean population. Korean J. Lab. Med. 2010, 30, 477-484.
239. Plebani, J.G.; Tirado, C.F.; Pettinati, H.M.; Kampman, K.M.; Volpicelli, J.R.; Oslin, D.W. Combined effects of alcohol and hepatitis C: A secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcoholdependence. Addict. Behav. 2010, 35, 123-128.
240. Stokbroekx, M.A.; Houterman, S.; Coolen, S.A.; van der Lely, N.; Pelleboer, R.A. Are carbohydrate-deficient transferrin assays useful for the detection of recurrent “binge drinking” in children with an alcohol intoxication in the emergency department? Alcohol Alcohol. 2014.
241. Stibler, H.; Jaeken, J. Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch. Dis. Child. 1990, 65, 107-111.
242. Stibler, H.; Jaeken, J.; Kristiansson, B. Biochemical characteristics and diagnosis of the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr. Scand. 1991, 375, 21-31.
243. Wada, Y.; Nishikawa, A.; Okamoto, N.; Inui, K.; Tsukamoto, H.; Okada, S.; Taniguchi, N. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem. Biophys. Res. Commun. 1992, 189, 832-836.
244. Hagberg, B.A.; Blennow, G.; Kristiansson, B.; Stibler, H. Carbohydrate-deficient glycoprotein syndromes: Peculiar group of new disorders. Pediatr. Neurol. 1993, 9, 255-262.
245. Yamashita, K.; Ideo, H.; Ohkura, T.; Fukushima, K.; Yuasa, I.; Ohno, K.; Takeshita, K. Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. J. Biol. Chem. 1993, 268, 5783-5789.
246. Wuyts, B.; Delanghe, J.R.; Kasvosve, I.; Gordeuk, V.R.; Gangaidzo, I.T.; Gomo, Z.A. Carbohydrate-deficient transferrin and chronic alcohol ingestion in subjects with transferrin CD-variants. Clin. Chem. Lab. Med. 2001, 39, 937-943.
247. De Wolf, H.K.; Huijben, K.; van Wijnen, M.; de Metz, M.; Wielders, J.P. A novel C2 transferrin variant interfering with the analysis of carbohydrate-deficient transferrin. Clin. Chim. Acta 2011, 412, 1683-1685.